Importance of NGS testing for STK11 and KEAP1 mutation and impact on treatment selection

Faculty: Charu Aggarwal, MD, MPH; Biagio Ricciuti, MD, PhD
Disclosures

Downloadable Slides

Panelists

Charu Aggarwal, MD, MPH

Physician Leader, Airways Malignancies Research Director
Precision Oncology Innovation, Penn Center for Cancer Care Innovation
Section Chief, Head & Neck and Thoracic Cancers, Hematology-Oncology
Leslye M. Heisler Professor for Lung Cancer Excellence
Penn Medicine

Biagio Ricciuti, MD, PhD

Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Harvard Medical School

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading